A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

BACKGROUND: CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing molecularly guided therapy versus platinum‐based chemotherapy in patients newly diagnosed with “unfavorable” cancer of unknown primary (CUP). MATERIALS AND METHODS: Patients with an unfavorable CUP diagnosis, as defi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauli, Chantal, Bochtler, Tilmann, Mileshkin, Linda, Baciarello, Giulia, Losa, Ferran, Ross, Jeffrey S., Pentheroudakis, George, Zarkavelis, George, Yalcin, Suayib, Özgüroğlu, Mustafa, Beringer, Andreas, Scarato, Jeremy, Mueller‐Ohldach, Mathis, Thomas, Marlene, Moch, Holger, Krämer, Alwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100559/
https://www.ncbi.nlm.nih.gov/pubmed/33687747
http://dx.doi.org/10.1002/onco.13744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100559/
https://www.ncbi.nlm.nih.gov/pubmed/33687747
http://dx.doi.org/10.1002/onco.13744

Ejemplares similares